Jenko Pražnikar, Zala
Mohorko, Nina
Valenčič, Vasilij
Valetič, Vasja
Gmajner, Dejan
Morosetti, Marco
Orlando, Patrick
Petelin, Ana https://orcid.org/0000-0002-5557-5974
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparative study of the bioavailability of two coenzyme Q10 products following single-dose and 3-week oral administration in healthy adults
https://doi.org/10.1186/s43094-026-00999-4
Funding for this research was provided by:
Javna Agencija za Raziskovalno Dejavnost RS (P1-0386)
Javna Agencija za Raziskovalno Dejavnost RS (IO-0035)
Article History
Received: 20 February 2026
Accepted: 19 May 2026
First Online: 28 May 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the by the National Medical Ethics Committee of Slovenia (No. 0120-557/2017/4; Ministry of Health, Republic of Slovenia) and registered on ClinicalTrials.gov (NCT06736366). Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.
: Not applicable.
: The study was supported by Biostile Ltd, which provided the food supplements. Authors Dejan Gmajner, Vasilij Valenčič, and Vasja Valetič are employees of Biostile Ltd and contributed to the paper as researchers in the company, which produces food supplements. However, the company had no role in the design, execution, interpretation, or writing of the study. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. Therefore, there is no conflict of interest in relation to Biostile Ltd. The authors declare that this study received funding from Biostile Ltd. The funder was involved only in providing food supplements and was not involved in the study design, data collection, analysis, interpretation, writing of the article, or the decision to submit it for publication.